Speakers: Melanie Goisauf and Mónica Cano Abadía (BBMRI-ERIC) Artificial Intelligence (AI) applications in medicine are hoped to improve healthcare and to advance health equity. While the technology carries the potential […]
“Get insights from the outside” – that is the motto for the consultation hours on quality-related topics in the field of biobanking and biomedical research and development. We invite you […]
For our first BBMRI.QM Newsroom of 2023, we will be welcoming two guests: Aulikki Santavuori (Auria Biobank Quality Manager - BBMRI.fi) Phil Scordis (UCB - project partner in the IMI […]
Biobank legislation is not harmonised at the European Union level, and the Member States have taken considerably divergent approaches in how they regulate the field. Whereas some countries do not […]
A live-learning webinar with the topic 'Validation and verification of processing methods and biobanking' presented by key expert Fay Betsou will be held on 1 June,1:00-2:15 pm CEST via Zoom. We […]
The second session in 2023 will be held on 7 June, 10:00-11:00 am CEST via Zoom. We will welcome two guests: Judit Balogh (Senior Project Manager at BBMRI-ERIC) Saba Abdulghani […]
The third session in 2023 will be held on 26 September, 10:00-11:00 am CEST via Zoom. We will welcome two guests: Claire Connellan (ERINHA, Project Manager ISIDORe) Lukasz Kozera (Scientific Programme Manager […]
Join the EBW Roadshow Innsbruck meeting led by BBMRI-ERIC and ESBB for an exciting two-day conference, focusing on the following main topics: health & biobank data integration, data management and […]
Integrating sex and gender in medical research is crucial to ensure that medical treatments and therapies are more personalized and effective for everyone. Considering gender factors such as social, cultural, […]
Organoids are defined as three-dimensional (3D) cell culture systems that can be called “mini-organs” as they mimic some of the key multicellular, anatomical and even functional characteristics of real organs. […]
This webinar is dedicated to explaining the cost recovery model that biobanks/biobankers can use to calculate the costs associated with sample and data provision in order to stay sustainable. This […]
Genomics is a rapidly evolving field constantly breaking down the boundaries of cost and time efficiency of analysis. Lately, translational and clinical researchers are also looking beyond the genome – […]
